Pure Global

Cancer Antigen CLIA - India CDSCO Medical Device Registration

Cancer Antigen CLIA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000083_d8ef9466d9d06bd8c4c1ef548c799740_f1b225e2fbc2eedb6bfa1ee913999093. This device is marketed under the brand name CA 19-9. The license holder is HAPTEN BIOSYSTEMS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Cancer Antigen CLIA
UID: IMP/IVD/2021/000083_d8ef9466d9d06bd8c4c1ef548c799740_f1b225e2fbc2eedb6bfa1ee913999093

Brand Name

CA 19-9

Device Class

Class C

Approving Authority

CDSCO

Product Information

For the quantitative determination of Cancer Antigen 15-3 (CA 19-9) concentration in Human serum by a Microplate chemiluminescence assay

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing